Foreword-Richard Wahl
Preface- Stanley J. Goldsmith, Cumali Aktolun
I. RadionuclideTherapy of Malignant Diseases
1) Lymphoma-SJ Goldsmith (USA)
2) Leukemia-A Abi-Ghanem (USA)
3) Myeloproliferative Neoplasms-E Silberstein (USA)
4) Neuroendocrine Tumors-E Bombardieri (Italy)
5) Bone Metastases and Bone Pain-A Abi-Ghanem (USA)
6) Melanoma-R Uren (Australia)
7) Brain Tumors-G Paganelli (Italy)
8) Well Differentiated ThyroidCarcinomas-E Bombardieri (Italy)
9) Medullary Carcinoma of Thyroid-F Chatal (France)
10) Breast Carcinoma-G Paganelli (Italy)
11) Liver Tumors-Radiomicrosphere Therapy-S Gulec (USA)
12) Liver Tumors-Systemic Radionuclide Therapy-C Divgi (USA)
13) Colo-rectal Carcinoma-D Goldenberg (USA)
14) Pancreatic Carcinoma-R Sharkey (USA)
15) Renal Cell Carcinoma-C Divgi (USA)
16) Prostate Carcinoma-SJ Goldsmith (USA)
II. RadionuclideTherapy of Benign Diseases
17) Radioiodine Therapy of Benign Thyroid Diseases-C Aktolun (Turkey)
18) Radiosynoviorthesis-G Moedder (Germany)
III. Special Topics in RadionuclideTherapy
19) Chemistry of Therapeutic Radiopharmaceuticals-S Vallabhajasula (USA)
20) Pretargeting: Advancing the Delivery of Therapeutic Radionuclides-
Sharkey (USA)
21) Radiobiology and Low Dose Rate Radiation Effects-D Murray (Canada)
22) Radiation Safety Considerations for Radionuclide Therapy-P Zanzanico
(USA)
23) Challenges Associated with Radionuclide Therapy-C Aktolun (Turkey)
VII. Index
